It needs shareholder approval..I'm voiting against it, if this person is keen, he will need to buy on market. ORD was trading under 4 cents for a while, looks like he will miss the boat!
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%